[Federal Register Volume 62, Number 171 (Thursday, September 4, 1997)]
[Notices]
[Pages 46742-46743]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-23577]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Clinical Laboratory Improvement Advisory Committee (CLIAC) 
Meeting

FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT: FR Doc. 97-21100 
Filed 8/8/97. Published 8/11/97 (Volume 62, Number 154, Pages 42997-
42998).

PREVIOUSLY ANNOUNCED TIMES AND DATES OF THE MEETING: 8:30 a.m.-4:30 
p.m., September 11, 1997, 8:30 a.m.-4:30 p.m., September 12, 1997.

CHANGES TO THE NOTICE: Addition to the announced agenda: For the 
afternoon of September 11, discussion of the new FDA category ``home 
use with a prescription'' and considerations for waiver of such 
laboratory tests under the Clinical Laboratory Improvement Amendments 
regulations.

CONTACT PERSON FOR MORE INFORMATION: John Ridderhof, Dr. P.H., Division 
of Laboratory Systems, Public Health Practice Program Office, CDC, 4770 
Buford Highway, NE, MS G25, Atlanta, Georgia 30341-3724, telephone 770/
488-7660.


[[Page 46743]]


    Dated: August 29, 1997.
Carolyn J. Russell,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 97-23577 Filed 9-2-97; 1:35 pm]
BILLING CODE 4163-18-P